Navigation Links
Hospira Reports Second-Quarter 2011 Results
Date:7/27/2011

rges relate to facilities optimization from the closure or departure from certain manufacturing and research and development ("R&D") facilities and include costs for severance and other employee benefits, accelerated depreciation and relocation of production and R&D operations.(C)

Amortization of certain intangible assets reported in Cost of products sold resulting from acquisitions including Mayne Pharma and a generic injectable business by Hospira India.(D)

Certain quality and product related charges reported in Cost of products sold primarily include third party oversight and consulting costs and penalties for failure to supply certain product to customers. These charges are directly associated with Hospira's response to the United States Food and Drug Administration ("FDA") Warning Letter received in April 2010.(E)

Acquisition and integration-related charges: $1.2 million reported in Research and development and $(1.0) million reported in Selling, general and administrative. These charges include acquisition and integration costs resulting from acquisitions including Javelin Pharma and a generic injectable business by Hospira India.(F)

Retractable Technologies, Inc. (“RTI”) litigation settlement and related charges reported in Selling, general and administrative.(G)

Research and development charge resulting from an initial payment related to an agreement with DURECT and corresponding milestone reached for development of a long-acting local anesthetic product that has not yet achieved regulatory approval.(1)

Gross profit is defined as Net sales less Cost of products sold.(2)

Adjusted Net Income is shown net of tax of $7.0 million and $35.7 million for the three months ended June 30, 2011 and 2010, respectively, based on the statutory tax rate in the various tax jurisdictions in which the adjustments occurred.(3)

The Non-GAAP financial measures contained in this press release (including ad
'/>"/>

SOURCE Hospira, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. Hospira to Host Conference Call for Second-Quarter 2011 Results
2. Hospira Receives Health Canada Regulatory Approval for Symbiq™ Infusion System Software Upgrade
3. Hospira to Present at the Sanford C. Bernstein Twenty-Seventh Annual Strategic Decisions Conference 2011
4. Hospira Highlights Progress in 2010 at Its 2011 Annual Meeting of Shareholders
5. Hospira Reports First-Quarter 2011 Results
6. Hospira Board Authorizes $1 Billion Share Repurchase Program
7. Hospira to Present at Bank of America / Merrill Lynch 2011 Health Care Conference May 11, 2011
8. Hospira Reinforces Importance of Clinical Surveillance Technology in Line With World Health Day Focus on Antimicrobial Resistance
9. Hospira to Host Conference Call for First-Quarter 2011 Results
10. Hospira Submits 510(k) Application to FDA for Symbiq™ Infusion System Modifications
11. Hospira Launches Enhanced TheraDoc™ Clinical Surveillance System to Support Patient Safety and Help Improve Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... 28, 2015 Research and ... the "Investigation Report on China,s Ranibizumab Market, 2012-2019" ... Novartis, ranibizumab was approved by CFDA to treat wet ... Lucentis, a product of Novartis, is available in the ... self- developed drug for the treatment of wet AMD ...
(Date:8/28/2015)... N.J. , Aug. 28, 2015  IP Shakti, LLC, ... LLC. ... "Our new corporate identity signifies our transformation ... world,s first predictive analytics platform for patent claim validity." ... the launch of the proprietary AIA Shield™ platform, the Company ...
(Date:8/28/2015)... 28, 2015  Perrigo Company plc ("Perrigo") (NYSE: ... the acquisition of leading OTC brands from GSK in ... transaction is a clear demonstration of Perrigo,s unique ability ... distribution network spanning 36 countries.  Perrigo ... commented, "We are excited to complete this transaction, which ...
Breaking Medicine Technology:Investigation Report on China's Ranibizumab Market, 2012-2019 2IP Shakti, LLC Changes Company Name to Prediqtus, LLC 2Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 2Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 3Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 4
... Inc. (Nasdaq: BMRN ) will host a ... Thursday, December 8, 2011 from 8:00 a.m. to 12:00 ... City.  Members of BioMarin,s management team and industry experts ... and advancements in the research and development pipeline.Dial-in informationToll-free ...
...  On July 20-22, 2012, the third ... Symposium will be held at the new luxury hotel, ... of revitalized lower Manhattan. This interactive, multidisciplinary symposium will ... innovative developments in the field from around the globe. ...
Cached Medicine Technology:BioMarin to Host a Research and Development Day on December 8th 2Third Aesthetic Plastic Surgery & Anti-Aging Medicine: The Next Generation Symposium Will Feature Newest Advancements in Dermal Fillers and Energy Based Devices 2
(Date:8/28/2015)... (PRWEB) , ... August 28, 2015 , ... An online ... decision to make the purchase of CPAP equipment more affordable by offering shipping at ... all types of CPAP products and orders of any size. My Cpap Store is ...
(Date:8/28/2015)... ... 28, 2015 , ... The Kentucky State Department of Workforce Investment Commissioner Beth ... are applying for, they are unable to pass the initial drug test and therefore ... policies in order to be able to hire long-term, skilled talent. (1) Will Wesch, ...
(Date:8/28/2015)... ... ... With the goal of furthering music education programs in schools, the “Music ... Fairgrounds in Mendon, IL on May 30th, 2015. Backed once again by Best Drug ... underfunded school districts of Mendon and its neighboring town of Quincy, IL. Best Drug ...
(Date:8/28/2015)... Church, VA (PRWEB) , ... ... ... Cybersecurity Risk Management for Medical Devices:, Understanding the FDA’s Position and Best ... Rockville, MD, http://www.fdanews.com/cybersecuritymd , This workshop, chaired by internationally renowned ...
(Date:8/28/2015)... ... August 28, 2015 , ... The 6th Annual Survivor in ... Foundation has added yet another accolade to its cadre of widespread support—an official letter ... “With the help of the medical community and the University of Illinois at Chicago’s ...
Breaking Medicine News(10 mins):Health News:My Cpap Store Now Offering Delivery Special 0 Cost to You 2Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 2Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 3Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 4Health News:Best Drug Rehabilitation Interviews Country-Rock Duo Highway Run at the 2015 "Music With A Mission" Benefit Concert 2Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 2Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 3Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 4Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 5Health News:Chicago Mayor Pens Official Support of Annual Survivor in the City Event Benefitting Brain Aneurysm Foundation 2Health News:Chicago Mayor Pens Official Support of Annual Survivor in the City Event Benefitting Brain Aneurysm Foundation 3
... to health care , , FRIDAY, Jan. 30 (HealthDay News) ... regular source of health care are the most likely to ... C.S. Mott Children,s Hospital report. , The findings show that ... of vulnerable children, said the researchers, who noted the number ...
... BCRX ) today announced that its fourth quarter and ... February 6, 2009. Following the release, BioCryst will host a ... to discuss the financial results and provide an update on ... P. Stonehouse, President and Chief Executive Officer, Stuart Grant, Chief ...
... 30 Neurosilicon,s novel Photoconductive Stimulation Device (PSD) was ... Colicos titled, Astrocytic Ca2+ Waves Guide CNS Growth Cones ... in the November 2008 issue of The Public Library ... neuronal activity in mediating axonal guidance. It is known ...
... N.J., Jan. 30 The assets of Trimlife ( ... have been acquired by The Neutraceutical Company, LLC of ... ). Trimlife offered the successful weight-loss product Lipitone ( ... Lipitone franchise as well as introduce additional wellness products ...
... LCAV ), a leading provider of laser vision correction ... it will release fourth quarter and full year 2008 financial ... A conference call and webcast to discuss the results ... 10:00 a.m. Eastern time.To access the conference call, dial 866-322-1352 ...
... 30 Patient Safety Technologies (OTC Bulletin Board: ... $2.55 million of new senior notes with net ... financing will go primarily towards funding the continued ... the leading provider of tracking systems for ...
Cached Medicine News:Health News:Medical Needs of 6.2 Million U.S. Kids Go Unmet 2Health News:BioCryst Pharmaceuticals to Announce Fourth Quarter and Year End 2008 Financial Results on February 6, 2009 2Health News:BioCryst Pharmaceuticals to Announce Fourth Quarter and Year End 2008 Financial Results on February 6, 2009 3Health News:Novel Photoconductive Cellular Depolarization Technology Reveals Insight Into Neuronal Growth, Guidance, and Regeneration 2Health News:The Neutraceutical Company, LLC Grows Wellness Enhancement Business with Acquisition of North Dakota Based Trimlife.com 2
... line offer patented Sensomatic® handles ... picked up and switch off ... delivery of light from 2.5V ... illumination of examination area. ...
Otoscope with 4X magnification lens, swivellable to both sides, with removable cover glass to insert external instruments. Sealed system allowing for pneumatic otoscopy. 3.5V halogen source....
Fiber optic illumination with XHL xenon halogen illumination. Large-diameter glass viewing window with 3X magnification, airtight window seal and swivelling viewing window....
Compact format, fiber optic illumination for uniform reflection-free light. Polycarbonate housing with chrome-plated cone....
Medicine Products: